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Background: The Lipoprotein-apheresis (LA) devices used in North America for Familial Hypercholesterolemia (FH) reduce LDL-C (- 80%) by 
binding positive charged apolipoprotein B (apoB) to a negative charged environment. FH patients also have low HDL-C levels, and despite their 
negative charge, HDL-C is acutely reduced by LA (4-32%) but increased over long term therapy. Previous studies have demonstrated LA’s selective 
removal of both inflammatory and apoE-bound HDL.
objective: To determine the effects of different LA devices on the plasma concentration of HDL-C, apoA1, and HDL particles (HDL-P).
methods: We examined 26 (F=18) FH patients receiving bi-weekly LA with either the HELP Futura (B.Braun), which filters 3000 mL of plasma per 
treatment, or the Liposorber, MA-03 (Kaneka), which filters, on average, 4500 mL of plasma. Labs were measured immediately before and after LA. 
The paired Student’s t test for normally distributed variables and a sign rank test for non-parametric variables were used for statistical analysis.
results: (see table) HDL-C and apoA1 decreased by 24% and 11% (p=0.001) while HDL-P increased by 16% (p<0.001). HDL-P increase was 
greater with the Liposorber system (p=0.002).
conclusions: LA appears to selectively reduce an HDL-C molecule with low apoA1 and HDL-P. The Liposorber system significantly increases 
HDL-P more, which may be attributed to the volume of treated plasma or through another mechanism. Further research is needed to evaluate the 
significance of these observations. 











HDL-P 28.65 32.70 16.11 <0.001 5.42 28.58 0.002
apoA1 124.58 109.27 (-)10.82 <0.001 (-)15.89 (-)4.9 0.400
HDL 47.54 34.92 (-)24.27 <0.001 (-)28.87 (-)18.91 0.504
apoA1/HDL 2.81 3.33 22.05 <0.001 20.14 24.29 0.979
HDL-P/HDL 0.65 1.01 62.99 <0.001 52.40 75.34 0.471
HDL-P/apoA1 0.24 0.31 32.56 <0.001 26.52 39.61 0.165
LDL 162.31 54.27 (-)65.45 <0.001 (-)60.96 (-)70.70 0.004
LDL-P 2401.15 854.85 (-)63.16 <0.001 (-)56.59 (-)70.83 0.004
LDL-P/HDL-P 90.43 28.42 (-)65.40 <0.001 (-)56.69 (-)75.56 0.001
